COATED DIBASIC CALCIUM PHOSPHATE

An oral formulation containing an active pharmaceutical ingredient, for instance a peptide pharmaceutical, such as insulin, coated onto a suitable particulate substrate, such as dibasic calcium phosphate. The oral formulation may be a modified release formulation, for instance a controlled release f...

Full description

Saved in:
Bibliographic Details
Main Authors RUFF, MICHAEL, D, COBB, JOSEPH, E., JR
Format Patent
LanguageEnglish
French
Published 27.05.2004
Edition7
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:An oral formulation containing an active pharmaceutical ingredient, for instance a peptide pharmaceutical, such as insulin, coated onto a suitable particulate substrate, such as dibasic calcium phosphate. The oral formulation may be a modified release formulation, for instance a controlled release formulation or a sustained release formulation, or may be an immediate release formulation. Also, the formulation may be encapsulated in gelatin capsules or may be compressed into tablets. Préparation pour administration per os contenant un principe pharmaceutique actif, par exemple une substance pharmaceutique peptidique telle que l'insuline, appliquée sur un substrat particulaire approprié, du phosphate de calcium dibasique notamment. Cette préparation peut être du type à libération modifiée, contrôlée ou immédiate. De plus, elle peut être intégrée dans des capsules de gélatine ou se présenter sous forme de comprimés.
Bibliography:Application Number: WO2003US35075